Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
A Single-center, Single-blind Phase II Clinical Trial of Acupuncture for the Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Malignant Tumors
1 other identifier
interventional
138
1 country
1
Brief Summary
A study on the efficacy and safety of acupuncture for the prevention and treatment of oral-related complications caused by radiotherapy for head and neck malignant tumors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2023
CompletedFirst Submitted
Initial submission to the registry
January 30, 2024
CompletedFirst Posted
Study publicly available on registry
February 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2025
CompletedFebruary 22, 2024
February 1, 2024
1 year
January 30, 2024
February 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Xerostomia questionnaire scores
Patients self-evaluated xerostomia according to Xerostomia questionnaire(score 0-100);Higher score indicates more severe symptoms
1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment
Secondary Outcomes (12)
Salivary flow rate
1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment
Taste function assessed by patients
1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment
Taste function assessed by electrogustometer test
1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment
Taste function assessed by taste strips test
1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment
Oral mucositis
1 week before radiotherapy;twice a week during the treatment(usually every 3 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment
- +7 more secondary outcomes
Study Arms (2)
treatment group
EXPERIMENTALverum acupuncture
control group
SHAM COMPARATORsham acupuncture
Interventions
Eligibility Criteria
You may qualify if:
- Patients diagnosed with malignant tumors of the head and neck without metastasis
- Age ≥18, ≤80 years old
- ZPS score ≤2
- Receiving radiotherapy alone or concurrent radiotherapy with a radiation dose of \>50 Gy, including at least one parotid gland
- Judged to be able to receive acupuncture treatment, with all needle positions identified as accessible
- Signed informed consent form
You may not qualify if:
- History of dry mouth, Sjogren's syndrome, or other underlying systemic condition known to cause dry mouth
- Suspected or confirmed physical closure of both salivary gland ducts
- Have a phobia of needles or prohibit the use of acupuncture at any acupuncture points
- Have a history of head and neck radiotherapy
- Have contraindications to acupuncture, including but not limited to bleeding disorders, having skin infections, ulcers or frequent infections
- Have taken any medications or herbs within the past 30 days that may affect salivary function, plan to or eventually take such substances during the study period
- Poor oral hygiene or severe periodontitis
- Poor compliance
- Other patients who, in the opinion of the investigator, are not suitable for participation in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West China Hospital, Sichuan University
Chengdu, Sichuan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Xingchen Peng
West China Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 22, 2024
Study Start
July 25, 2023
Primary Completion
July 24, 2024
Study Completion
July 24, 2025
Last Updated
February 22, 2024
Record last verified: 2024-02